Free virtual event on MRI-guided radiation therapy for pancreatic cancer

September 27, 2023 Providence Cancer Institute of Oregon

Providence Cancer Institute is partnering with the Pancreatic Cancer Action Network (PanCAN) for a free virtual patient education event:

MRI-Guided Radiation Therapy and Pancreatic Cancer

Featured speaker: Amar J. Srivastava, M.D., MPH, radiation oncologist
Providence Cancer Institute and The Oregon Clinic
When: Thursday, Oct. 12, 2023, 5:30 - 7:00 p.m.

Register here

Everyone is invited to attend this important talk about MRI-guided radiation therapy and how it is used to treat pancreatic cancer. Providence was the first facility in the Pacific Northwest to offer the technology – the biggest advancement in radiation oncology in over two decades.

Unlike standard radiotherapy, MRI-guided radiation therapy allows radiation oncologists to precisely target and track a tumor. Physicians see in real time if a patient’s tumor has shifted due to movement from the bowels, regular breathing or a heartbeat. The precision and tracking ability of this technology helps reduce the effects of radiation on healthy tissue.

Earlier this year, Dr. Srivastava shared the benefits of MRI-guided radiation treatments:

About Dr. Amar J. Srivastava

Dr. Srivastava was first introduced to the field of Radiation Oncology when his brother-in-law was diagnosed with a glioblastoma. This experience showed Dr. Srivastava that a cancer diagnosis affects both a patient and their family and taught him to experience cancer care from the patient's perspective.

Dr. Srivastava was trained in Magnetic Resonance-Guided Radiation Therapy (MRgRT) during residency at the first center to utilize this technology in the U.S. and has over four years of experience with this technology. He is trained in MR-based adaptive radiotherapy, offered at The Oregon Clinic Radiation Oncology. Dr. Srivastava also brings extensive training in gynecologic and genitourinary high-dose rate brachytherapy, which is used to treat cervical/endometrial cancers and prostate cancers.

Learn more about MRI-Guided Radiation Therapy at Providence Cancer Institute.

Targeted therapies are the focus of new studies for colorectal and bile duct cancers

MRI-guided radiotherapy is a gamechanger in treating prostate cancer

Welcome to your journey for creating a healthier you

Free virtual event on MRI-guided radiation therapy for pancreatic cancer

MRI-Guided Radiation Therapy and Pancreatic Cancer

Previous Article

Next Article

Free virtual event on MRI-guided radiation therapy for pancreatic cancer

MRI-Guided Radiation Therapy and Pancreatic Cancer

Previous Article

Next Article

Other content in this Stream

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.

Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.

It took a total team effort to make a hospice patient’s dream come true of touching a horse before she died.

Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.

Providence Heart Institute welcomed patients and their families for the clinic’s third anniversary of its advanced heart failure clinic.

Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.

Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.

The Springs Living has made a generous gift to Providence Foundations of Oregon to establish The Springs Living Regional Chair of Geriatric Medical Education.

For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.

New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

Beginning Tuesday, Aug. 15, many Alaris infusion pumps at Providence will begin integrating with Epic. See which hospitals and units are affected and what to expect.

Early next year an expansion of our Warrenton Clinic will begin to bring more services to the North Coast community.

Two breast cancer survivors whose stories intersect in a miraculous way, threw the first pitches at the Medford Rogues annual Paint the Park Pink event. Read their story.

In 2021, Dr. Nicole Schmidt was driving around a curve when she saw a car headed straight for her. The crash sent her to a trauma center and started a journey of healing, learning and becoming.

Magnet recognition is the highest national honor for professional nursing practice. This redesignation makes St. Vincent the 12th hospital in the world to obtain Magnet designation six times.

Each year, Providence ministries identify unmet needs and respond with strategic investments in community health. See how we worked to answer the call of our Mission in 2022.

A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.